- 期刊
Safety and Efficacy of Intravenous Ferric Carboxymaltose (750 mg) in the Treatment of Iron Deficiency Anemia: Two Randomized, Controlled Trials
延伸閱讀
- Hussain, I., Bhoyroo, J., Butcher, A., Koch, T. A., He, A., & Bregman, D. B. (2013). Direct Comparison of the Safety and Efficacy of Ferric Carboxymaltose versus Iron Dextran in Patients with Iron Deficiency Anemia. Anemia, 2013(), 6-15. https://doi.org/10.1155/2013/169107
- Porter, J., Bowden, D. K., Economou, M., Troncy, J., Ganser, A., Habr, D., Martin, N., Gater, A., Rofail, D., Webb, L. A., Lau, H., & Cappellini, M. D. (2012). Health-Related Quality of Life, Treatment Satisfaction, Adherence and Persistence in β-Thalassemia and Myelodysplastic Syndrome Patients with Iron Overload Receiving Deferasirox: Results from the EPIC Clinical Trial. Anemia, 2012(), 98-107. https://doi.org/10.1155/2012/297641
- Wu, Q., Wang, Y., Wang, W., Zhang, Y., Yan, W., Lu, L., Tao, Y., & Tang, Q. (2013). Efficacy and safety of parenteral nutrition with iron sucrose for anemia prevention in preterm infants: A randomized, double-blind controlled study. Asia Pacific Journal of Clinical Nutrition, (), 1-15. https://doi.org/10.6133/apjcn.202203/PP.0004
- Wu, Q., Wang, Y., Wang, W., Zhang, Y., Yan, W., Lu, L., Tao, Y., & Tang, Q. (2022). Efficacy and safety of parenteral nutrition with iron sucrose for anemia prevention in preterm infants: A randomized, double-blind controlled study. Asia Pacific Journal of Clinical Nutrition, 31(2), 222-228. https://doi.org/10.6133/apjcn.202206_31(2).0008
- Ott, C., Liebold, A., Takses, A., Strauch, U. G., & Obermeier, F. (2012). High Prevalence but Insufficient Treatment of Iron-Deficiency Anemia in Patients with Inflammatory Bowel Disease: Results of a Population-Based Cohort. Gastroenterology Research and Practice, 2012(), 659-665-099. https://doi.org/10.1155/2012/595970